Understanding Trends and Challenges in the Behavioral Health Sector
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 200: Athlete Mental Health and Physical Conditioning With Dawn Staley
AGG Talks: Healthcare Insights Podcast - Episode 4: What to Do When Insurance Companies Deny Behavioral Health Claims
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 189: Student Mental Health with Dr. Stephanie Irby Coard, UNC Professor
What's the Tea in L&E? Is Your Workplace "Toxic?" Best Practices for Psychological Safety
Addiction and the Recovery Journey for Lawyers | Brian Cuban | Texas Appellate Law Podcast
Employee Assistance Programs & Career Balance – IMS Insights Podcast Episode 60
Mental Health in the Legal Field – IMS Insights Podcast Episode 59
Talking About Mental Health at Work – IMS Insights Podcast Episode 58
#WorkforceWednesday: Mental Health Awareness Month in the Workplace - Employment Law This Week®
Legal’s Mental Health Imperative
Compliance Into The Weeds - Mental Health and Compliance Officers
Responding to Trauma in the Workplace with Katharine Manning, President of Blackbird DC: On Record PR
What Can the Show Severance Teach Us About Work-Life Balance? - Hiring to Firing Podcast
A Slow Burn or a Burn Out: How to Know When You Are Past Your Limits
Taking the Pulse, A Health Care and Life Sciences Podcast | Episode 105: Sara Goldsby, Director, DAODAS
#WorkforceWednesday: Federal Focus on Mental Health, FTC and Noncompetes, Gig Work Risks for Hospitals - Employment Law This Week®
“Walking the Walk” on Lawyer Well-Being | Bree Buchanan
DE Under 3: EEOC & DOJ Technical Guidance for Employer’s AI Use; Upcoming EEOC Hearing; Event for Mental Health in the Workplace
DE Under 3: Best Practices, Webinars & Communication – Straight from Government Agencies
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
It is an old problem in medical care -- and human life. The stigma of some human conditions -- weight gain, mental health, substance abuse, and now monkey pox, to name a few -- brings shame. And shame brings silence. And...more
Prompted by rising rates of overdose deaths, suicides and incidence of mental illness in at-risk populations, such as children, Congress has spent the better part of the year working in a bipartisan manner to develop and...more
In January 2021, Manatt Health described the ten health care imperatives essential for improving our health care system and advancing health equity in the 2020s. Now two years into the decade, we have released our 2022...more
The plague of misinformation, disinformation and uncertainty swirling through our pandemic world has one distinct upside for our human brains.: the chance to better understand and cope with the cognitive biases that influence...more
Push to end surprise medical billing - The Senate Finance Committee heard from providers and health insurers on S.309, a bill that prohibits certain provisions in contracts between health insurers and health care...more
CONCERNS ABOUT CORONAVIRUS GROW ON CAPITOL HILL - As coronavirus cases continue to emerge in the United States and worldwide, lawmakers are seeking briefings from federal health officials about the outbreak that originated...more
On July 9, 2019, Connecticut Governor Ned Lamont signed into law Public Act No. 19-191 “An Act Addressing Opioid Use” (PA 19-191). PA 19-191 makes various revisions to Connecticut’s opioid use prevention and treatment...more
As previously discussed in our post from September 2017, the push for a response to the opioid crisis is gaining momentum. Enter the “Opioid Crisis Response Act of 2018.” On May 7, 2018, the Opioid Crisis Response Act of...more
Act 188 Plans On Hold as New Chemical Bill is Introduced - Nearly three years after the legislature passed a law to regulate children’s products containing chemicals of high concern, a web site intended to inform the...more
Those working in the pharmaceutical space are used to hearing complaints about the high costs of drugs, and patents often are blamed for allowing pharmaceutical companies to charge “too much” for their products. But are drug...more